Revisiting Randomized Controlled Trials: Reassessing Their Role as the Gold Standard for Evidence-Based Treatments
Psychodynamic Psychiatry · 2025
DOI: 10.1521/pdps.2025.53.2.157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychodynamic Psychiatry, 2025. Verfasst von Angela J Zaur. Beteiligte Einrichtung: Department of Psychology, Kent State University. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Psychotherapy, Evidence-Based Medicine, Evidence-Based Practice. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Randomized controlled trials (RCTs) have traditionally been the gold standard for determining whether a treatment is empirically supported. Nevertheless, there has been an increase in criticism of RCTs for psychotherapeutic research due to their high rate of biases, lack of replicability, and discrepancies in real-world applications. The author discusses the weaknesses of RCTs and the need to refine how we view psychotherapeutic treatments as efficacious.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Kent State University.
Zitieren
APA
Zaur, A. J. (2025). Revisiting Randomized Controlled Trials: Reassessing Their Role as the Gold Standard for Evidence-Based Treatments. Psychodynamic Psychiatry. https://doi.org/10.1521/pdps.2025.53.2.157
Vancouver
Zaur AJ. Revisiting Randomized Controlled Trials: Reassessing Their Role as the Gold Standard for Evidence-Based Treatments. Psychodynamic Psychiatry. 2025. doi:10.1521/pdps.2025.53.2.157
BibTeX
@article{Zaur2025,
author = {Zaur, Angela J},
title = {Revisiting Randomized Controlled Trials: Reassessing Their Role as the Gold Standard for Evidence-Based Treatments},
journal = {Psychodynamic Psychiatry},
year = {2025},
doi = {10.1521/pdps.2025.53.2.157}
}
EUVIMED